Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function-Reference-Cited by-同舟云学术

Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function

Published:2011-09 Issue:3 Volume:55 Page:435-440
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Wanninger Josef,Weigert Johanna,Wiest Reiner,Bauer Sabrina,Karrasch Thomas,Farkas Stefan,Scherer Marcus N.,Walter Roland,Weiss Thomas S.,Hellerbrand Claus,Neumeier Markus,Schäffler Andreas,Buechler Christa

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference34 articles.

1. Galectin-3: an open-ended story;Dumic;Biochim Biophys Acta,2006

2. Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation;Lippert;Clin Exp Immunol,2008

3. Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice;Nomoto;J Pathol,2006

4. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma;Hsu;Int J Cancer,1999

5. Galectin-3 regulates myofibroblast activation and hepatic fibrosis;Henderson;Proc Natl Acad Sci USA,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression;Current Issues in Molecular Biology;2024-07-25

2. Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities;International Journal of Molecular Sciences;2024-05-28

3. Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease;Hepatology;2024-05-01

4. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis;International Journal of Molecular Sciences;2024-04-27

5. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease;Protein & Peptide Letters;2024-04